Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity.

Molecular and cellular biology·2026
Same author

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026
Same author

The role of mTORC2 in the in vitro neurotoxicity of Parkinsonian mimetics 6-OHDA and MPP<sup></sup>.

Neurotoxicology·2026
Same author

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

eLife·2026
Same author

Comparison of CX-4945 and SGC-CK2-1 as inhibitors of CSNK2 using quantitative phosphoproteomics: Triple SILAC in combination with inhibitor-resistant CSNK2.

Current research in chemical biology·2026
Same author

Corrigendum to 'The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma': [Journal of Investigative Dermatology, Volume 135, Issue 5, May 2015, Pages 1368-1376].

The Journal of investigative dermatology·2026

Related Experiment Video

Updated: Mar 25, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

20.0K

Biomedical Potential of mTOR Modulation by Nanoparticles.

Laura Hulea1, Zoran Markovic2, Ivan Topisirovic1

  • 1Lady Davis Institute, SMBD Jewish General Hospital and Department of Oncology, McGill University, 546 Pine Avenue West, Montreal, Quebec H2W 1S6, Canada.

Trends in Biotechnology
|February 23, 2016
PubMed
Summary

Engineered nanoparticles affect cellular balance by modulating the mammalian target of rapamycin (mTOR). Understanding nanoparticle-mTOR interactions can lead to new nanotherapeutics for treating diseases.

Keywords:
autophagycancercell deathmTORnanoparticlesoxidative stress

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

841
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
10:56

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale

Published on: May 17, 2014

70.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

20.0K
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

841
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
10:56

Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale

Published on: May 17, 2014

70.1K

Area of Science:

  • Biomedical Engineering
  • Cellular Biology
  • Nanotechnology

Background:

  • The mammalian target of rapamycin (mTOR) is a key regulator of cellular homeostasis.
  • Engineered nanoparticles exhibit diverse biological effects.
  • Nanoparticle interactions with cellular pathways are not fully understood.

Purpose of the Study:

  • To investigate the role of nanoparticle-mediated modulation of mTOR.
  • To elucidate the mechanisms underlying nanoparticle effects on cellular processes.
  • To explore the potential of targeting mTOR for nanotherapeutic development.

Main Methods:

  • Utilized engineered nanoparticles in cellular models.
  • Assessed mTOR pathway activation and downstream effects.
  • Analyzed cellular responses including death/survival and metabolism.

Main Results:

  • Demonstrated that engineered nanoparticles modulate mTOR signaling.
  • Observed significant impacts on cell death/survival pathways.
  • Identified alterations in cellular metabolic responses due to nanoparticle exposure.

Conclusions:

  • Nanoparticle-induced mTOR modulation is a critical mechanism for their biological actions.
  • Targeting mTOR offers a promising strategy for developing novel nanotherapeutics.
  • Further research into nanoparticle-mTOR interactions is essential for advancing nanomedicine.